A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy

P. L. Amlot, M. J. Stone, D. Cunningham, J. Fay, J. Newman, R. Collins, R. May, M. McCarthy, J. Richardson, V. Ghetie, O. Ramilo, P. E. Thorpe, J. W. Uhr, E. S. Vitetta

Research output: Contribution to journalArticlepeer-review

236 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds